Metabolic energy metabolism in diabetes: Therapeutic implications

Coronary Artery Disease

Volumn 12, Issue SUPPL. 1, 2001, Pages

  Pogatsa, G ^a  

^a Institute of Cardiology   (Hungary)

Author keywords

Cardiac metabolism; Diabetic heart; Ischaemic heart disease; Metabolic control; Trimetazidine

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE; INSULIN; PYRUVATE DEHYDROGENASE; TRIMETAZIDINE;

ANGINA PECTORIS; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENERGY METABOLISM; ENZYME ACTIVITY; FATTY ACID OXIDATION; GLUCOSE OXIDATION; GLYCOLYSIS; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL;

ANGINA PECTORIS; ANIMALS; CIRCADIAN RHYTHM; DIABETIC ANGIOPATHIES; ENERGY METABOLISM; GLYCOLYSIS; HUMANS; MYOCARDIAL REPERFUSION; MYOCARDIUM; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 0035085930     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Regulation of energy substrate metabolism in the diabetic heart
2. The glucose fatty-acid cycle, its role in insulin sensitivity and the metabalic disturbances of diabetes mellitus
3. Myocardial glucose transporters and glycolytic metabolism during ischaemia in hyperglycaemic diabetic swine
4. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work
5. Mitochondrial diabetes mellitus
6. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprorein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects
7. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute percutaneous transluminar coronary angioplasty registry
8. Diabetic cardiopathy, is it a real entity?
9. Metabolic effects of treadmill exercise training on the diabetic heart
10. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): Effects on mortality at 1 year
11. Some biochemical aspects of the protective effects of trimetazidine on rat cardiomyocites during hypoxia and reoxygenation
12. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl-coenzyme A thiolase
13. Anti-isahaemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart
14. Trimetazidine lowers free radical production in sequential ischaemia and re-perfusion
15. Further analysis of the results of Trimetazidine European Multicenter Study
16. Metabolic disturbances of myocardial energy supply in diabetes. Theraputic implications